Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hruby

Showing results (91-100 of 202) with videos related to

Pageof 21
Sort By:
Current Opinion in Virology|June 19, 2013
Antiviral options for biodefenseChelsea M Byrd, Douglas W Grosenbach, Dennis E Hruby
Virology Journal|December 13, 2005
Importance of disulphide bonds for vaccinia virus L1R protein functionRobert E Blouch, Chelsea M Byrd, Dennis E Hruby
Virus Research|July 7, 1999
Novel acylation of poxvirus A-type inclusion proteinsK H Martin, C A Franke, D E Hruby
Journal of Virology|October 1, 1989
Fatty acid acylation of vaccinia virus proteinsC A Franke, P L Reynolds, D E Hruby
The Journal of General Virology|March 1, 1995
Physical and molecular genetic analysis of the multistep proteolytic maturation pathway utilized by vaccinia virus P4a proteinS S Whitehead, N A Bersani, D E Hruby
Virology|February 1, 1986
Construction of a recombinant vaccinia virus which expresses immunoreactive plant virus proteinsW G Dougherty, C A Franke, D E Hruby
Virus Research|February 1, 1988
Inhibition of vaccinia virus replication by nicotinamide: evidence for ADP-ribosylation of viral proteinsS J Child, C A Franke, D E Hruby
Journal of Virology|May 4, 2007
The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virusKady M Honeychurch, Guang Yang, Robert Jordan, et al.
BMC Microbiology|July 3, 2004
Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incADamir Alzhanov, Jennifer Barnes, Dennis E Hruby, et al.
Viruses|October 14, 2011
Development of ST-246® for Treatment of Poxvirus InfectionsRobert Jordan, Janet M Leeds, Shanthakumar Tyavanagimatt, et al.
Pageof 21

Showing results (91-100 of 202) with videos related to

Sort By:
Pageof 21
Current Opinion in Virology|June 19, 2013
Antiviral options for biodefenseChelsea M Byrd, Douglas W Grosenbach, Dennis E Hruby
Virology Journal|December 13, 2005
Importance of disulphide bonds for vaccinia virus L1R protein functionRobert E Blouch, Chelsea M Byrd, Dennis E Hruby
Virus Research|July 7, 1999
Novel acylation of poxvirus A-type inclusion proteinsK H Martin, C A Franke, D E Hruby
Journal of Virology|October 1, 1989
Fatty acid acylation of vaccinia virus proteinsC A Franke, P L Reynolds, D E Hruby
The Journal of General Virology|March 1, 1995
Physical and molecular genetic analysis of the multistep proteolytic maturation pathway utilized by vaccinia virus P4a proteinS S Whitehead, N A Bersani, D E Hruby
Virology|February 1, 1986
Construction of a recombinant vaccinia virus which expresses immunoreactive plant virus proteinsW G Dougherty, C A Franke, D E Hruby
Virus Research|February 1, 1988
Inhibition of vaccinia virus replication by nicotinamide: evidence for ADP-ribosylation of viral proteinsS J Child, C A Franke, D E Hruby
Journal of Virology|May 4, 2007
The vaccinia virus F13L YPPL motif is required for efficient release of extracellular enveloped virusKady M Honeychurch, Guang Yang, Robert Jordan, et al.
BMC Microbiology|July 3, 2004
Chlamydial development is blocked in host cells transfected with Chlamydophila caviae incADamir Alzhanov, Jennifer Barnes, Dennis E Hruby, et al.
Viruses|October 14, 2011
Development of ST-246® for Treatment of Poxvirus InfectionsRobert Jordan, Janet M Leeds, Shanthakumar Tyavanagimatt, et al.
Pageof 21